4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001628280-22-016875
Chief Innovation/Tech Officer bought 45,871 shares at $0.96 ($44,036)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schobel Alexander Mark Chief Innovation/Tech Officer | 2022-06-08 | Purchase | +45,871 | $0.96 | $44,036 | 882,871 | D |
| Derivatives | |||||||
| Schobel Alexander Mark Chief Innovation/Tech Officer | 2022-06-08 | Purchase · Warrant (Right to Buy) | +45,871 | $0.13 | $5,963 | 45,871 | D |
| Open-market purchases · 45,871 sh · avg $0.96 · $44,036 | |||||||
Loading xslF345X03/wf-form4_165489638239475.xml…